Deepbridge Capital was formed in 2010 to build an investment team focused on growth capital and corporate governance. The firm provides financial backing and practical support to high-performance management teams.
Portfolio
2
companies
IbisVision
IbisVision develops remote ophthalmic technology enabling online eye examinations.
Thalia Design Automation
Thalia Design Automation develops software that enables semiconductor businesses to reuse existing chip designs.
Ray Eugeni
Partner
Ray brings investment and wealth management experience from roles at Deepbridge Capital, Coutts, and Barclays. He currently serves as a partner at Deepbridge.
LinkedInBen Carter
Head of Life Sciences
The Glasgow-based ophthalmic technology company has raised £4.5m from Compiler VC, Deepbridge, and Scottish Enterprise.
"The commitment of our investor base shows they believe strongly in our story — that eyecare will be at the vanguard of remote healthcare, and IbisVision has the technology to make this a reality. Our mission is simple – to make eyecare readily available for anyone on the planet and that distance and time will never be an impediment to getting to an eye appointment."
Deepbridge Capital led the Series A round with participation from the Development Bank of Wales to accelerate expansion into the US market.
"Deepbridge is committed to fostering innovation and growth in businesses with truly disruptive market potential, and we believe that Thalia definitely falls into that category,"
